Case Report: The Danger of Postchemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Nonseminomatous Testicular Carcinoma

2008 ◽  
Vol 22 (5) ◽  
pp. 1013-1016 ◽  
Author(s):  
J. Roan Spermon ◽  
J. Alfred Witjes
Keyword(s):  
Case Report ◽  
Lymph Node ◽  
Lymph Node Dissection ◽  
Retroperitoneal Lymph Node Dissection ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Testicular Carcinoma

Stage II nonseminomatous testicular cancer: a 10-year experience.

1983 ◽  
Vol 1 (3) ◽  
pp. 171-178 ◽  
Author(s):  
N J Vogelzang ◽  
E E Fraley ◽  
P H Lange ◽  
J Torkelson ◽  
S Levitt ◽  
...  
Keyword(s):  
Lymph Node ◽  
Adjuvant Chemotherapy ◽  
Germ Cell ◽  
Lymph Node Dissection ◽  
Stage Ii ◽  
Retroperitoneal Lymph Node Dissection ◽  
University Of Minnesota ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Testicular Carcinoma

Between 1970 and 1980, 82 patients with pathologic stage II nonseminomatous germ cell testicular carcinoma were treated at the University of Minnesota. Of the 30 patients treated with a retroperitoneal lymph node dissection, 22 (77%) relapsed. Of the 18 patients treated with retroperitoneal lymph node dissection and adjuvant radiotherapy, 12 (63%) relapsed. Sixteen patients received adjuvant chemotherapy before 1976, and 14 (87.5%) relapsed. After 1976, 18 patients received adjuvant chemotherapy (11 with cisplatin) and 2 (11%) have relapsed. No patient treated with cisplatin-based adjuvant chemotherapy has relapsed. The toxicity has been modest. Cisplatin-based chemotherapy is an effective and a safe adjuvant therapy for stage II nonseminomatous germ cell testicular carcinoma.

Sign in / Sign up

Export Citation Format

Share Document